Leveraging Adthena’s Whole Market View, this analysis explores recent trends in Google Ads for the US Oncology category from the last month. Our Data Analyst, Ask Arlo provides commentary on key findings.
See how often AIOs appear and how search intent is distributed across buying signals.
How often a Google AI overview appears on search terms relevant to this category.
| Frequency | Percentage |
|---|---|
| Frequency | 56.4194992436 |
| 43.5805007564 |
A complex query is a longer, more detailed search that often contains multiple keywords, specific conditions, or multi-part questions.
| Frequency | Percentage |
|---|---|
| Frequency | 30 |
| 70 |
Copyright © Adthena. All rights reserved.
Here are the Top 10 competitors in the industry by Share of Clicks for the last month.
| Domain | Share of clicks |
|---|---|
| mayoclinic.org | 6.5 |
| themmrf.org | 5.87 |
| breyanzi.com | 3.64 |
| lilly.com | 3.38 |
| cancer.org | 3.09 |
| kisqali.com | 2.7 |
| letschatcart.com | 2.3 |
| thermofisher.com | 2.24 |
| imbcr.org | 2.02 |
| her2know.com | 1.69 |
| others | 66.57 |
Copyright © Adthena. All rights reserved.
In the oncology PPC landscape, ‘others’ dominate with 66.57% click share. Mayo Clinic leads individual domains at 6.5%, followed by The MMRF at 5.87%.
Curious about your market position? Here you can see the Top 10 competitors in the industry by Share of Spend for the last month.
| Date | kisqali.com | mayoclinic.org | nubeqa-us.com | themmrf.org | kisqali-hcp.com | lilly.com | breyanzi.com | cancer.org | brukinsa.com | her2know.com |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025/11/01 | 5.89% | 4.14% | 2.57% | 1.91% | 1.29% | 5.7% | 3.18% | 1.88% | 0.86% | 3.27% |
| 2025/11/02 | 2.43% | 4.49% | 2.78% | 1.17% | 0.48% | 4.46% | 3.91% | 1.14% | 0.39% | 1.93% |
| 2025/11/03 | 7.59% | 3.09% | 3.2% | 2.37% | 1.92% | 9.42% | 2.62% | 1.65% | 2.53% | 2.11% |
| 2025/11/04 | 3.94% | 4.06% | 1.08% | 3.06% | 1.1% | 8.62% | 3.76% | 1.95% | 3.31% | 2.33% |
| 2025/11/05 | 1.96% | 4.74% | 4.01% | 6.59% | 0.7% | 3.07% | 3.47% | 2.4% | 5.89% | 2.82% |
| 2025/11/06 | 14.25% | 4.3% | 2.4% | 1.17% | 3.22% | 3.95% | 2.67% | 1.87% | 2.28% | 2.15% |
| 2025/11/07 | 7.54% | 4.22% | 1.98% | 6.18% | 2.2% | 3.69% | 2.13% | 3.11% | 0.58% | 2.21% |
| 2025/11/08 | 9.91% | 3.48% | 2.1% | 2.02% | 2.86% | 4.08% | 2.85% | 1.53% | 3.47% | 2.3% |
| 2025/11/09 | 6.93% | 3.27% | 1.91% | 7.38% | 2.57% | 7.54% | 2.01% | 2.66% | 0.79% | 1.62% |
| 2025/11/10 | 2.79% | 7.56% | 0.95% | 6.78% | 0.71% | 3.6% | 2.68% | 1.97% | 0.51% | 2.85% |
| 2025/11/11 | 19.1% | 3.47% | 0.39% | 7.17% | 4.19% | 3.7% | 3.43% | 2.3% | 0.49% | 2.2% |
| 2025/11/12 | 3.23% | 5.47% | 2.87% | 4.01% | 1.39% | 4.99% | 2.66% | 1.89% | 0.63% | 2.42% |
| 2025/11/13 | 8.08% | 4.12% | 3.35% | 4.03% | 3.23% | 3.91% | 2.45% | 1.18% | 2.62% | 1.92% |
| 2025/11/14 | 7.38% | 2.13% | 1.16% | 2.71% | 3.11% | 4% | 2.8% | 1.28% | 4.26% | 1.54% |
| 2025/11/15 | 12.5% | 4.22% | 2.34% | 3.76% | 3.43% | 4.51% | 3.12% | 0.93% | 2.41% | 3.06% |
| 2025/11/16 | 2.86% | 4.14% | 2.21% | 9.23% | 0.75% | 3.17% | 3.26% | 1.19% | 0.39% | 1.74% |
| 2025/11/17 | 3.75% | 1.34% | 2% | 6.43% | 1.48% | 3.21% | 2.7% | 1.04% | 2.08% | 2.38% |
| 2025/11/18 | 6.83% | 6.22% | 2.47% | 3.97% | 1.9% | 4.79% | 2.87% | 1.05% | 1.26% | 2.99% |
| 2025/11/19 | 0.65% | 3.7% | 2.55% | 2.68% | 0.3% | 5.22% | 3.18% | 1.14% | 0.73% | 3.06% |
| 2025/11/20 | 0.52% | 4.8% | 2.54% | 3.07% | 0.24% | 6.58% | 3.21% | 1.32% | 0.9% | 2.32% |
| 2025/11/21 | 0.41% | 4.4% | 2.26% | 6.07% | 0.18% | 3.92% | 3.5% | 1.02% | 1.06% | 2.59% |
| 2025/11/22 | 0.49% | 3.33% | 3.79% | 1.2% | 0.21% | 4.78% | 3.66% | 1.44% | 1.1% | 3.17% |
| 2025/11/23 | 0.36% | 2.75% | 0.51% | 1.61% | 0.16% | 2.64% | 2.18% | 2.07% | 5% | 3.11% |
| 2025/11/24 | 0.99% | 3.96% | 2.01% | 6.29% | 1.07% | 2.84% | 3.01% | 3.6% | 4.19% | 1.77% |
| 2025/11/25 | 2.74% | 4.57% | 1.87% | 4.76% | 1.78% | 3.26% | 3.72% | 2.71% | 2.01% | 1.17% |
| 2025/11/26 | 4.75% | 3.4% | 1.48% | 4.21% | 3.19% | 3.45% | 3.42% | 1.3% | 3.6% | 1.06% |
| 2025/11/27 | 4.24% | 4.59% | 1.69% | 7.76% | 1.91% | 2.56% | 2.86% | 0.93% | 1.43% | 2.07% |
| 2025/11/28 | 4.1% | 7.38% | 3.53% | 6.74% | 2.55% | 2.5% | 3.53% | 0.55% | 1.06% | 1.09% |
| 2025/11/29 | 4.66% | 9.84% | 1.53% | 4.26% | 3.09% | 2.74% | 3.22% | 2.01% | 1.38% | 1.39% |
| 2025/11/30 | 5.17% | 4.67% | 4.58% | 3.1% | 2.72% | 2.64% | 2.38% | 1.47% | 1.22% | 0.69% |
Copyright © Adthena. All rights reserved.
In November 2025, kisqali.com saw fluctuating PPC spend, peaking at 19.10 on the 11th. Mayoclinic.org maintained steady spending, with a notable spike on the 29th at 9.84. Nubeqa-us.com had a consistent pattern, ending with a rise to 4.58. Themmrf.org experienced a peak on the 16th at 9.23. Kisqali-hcp.com showed a gradual increase, peaking at 4.19 on the 11th. Lilly.com had a strong start, peaking at 9.42 on the 3rd. Breyanzi.com maintained moderate spending, with a peak on the 25th at 3.72. Cancer.org had a steady month, peaking at 3.60 on the 24th. Brukinsa.com saw a peak on the 5th at 5.89. Her2know.com had a consistent month, ending with a dip to 0.69.
Ever wondered how many competitors you’re up against in your industry? Well look no further, here we can see the number of advertisers bidding over the last month.
| Date | Competitor Count |
|---|---|
| 2025/11/01 | 450 |
| 2025/11/02 | 458 |
| 2025/11/03 | 465 |
| 2025/11/04 | 453 |
| 2025/11/05 | 453 |
| 2025/11/06 | 451 |
| 2025/11/07 | 446 |
| 2025/11/08 | 444 |
| 2025/11/09 | 440 |
| 2025/11/10 | 448 |
| 2025/11/11 | 440 |
| 2025/11/12 | 452 |
| 2025/11/13 | 454 |
| 2025/11/14 | 463 |
| 2025/11/15 | 454 |
| 2025/11/16 | 453 |
| 2025/11/17 | 457 |
| 2025/11/18 | 456 |
| 2025/11/19 | 456 |
| 2025/11/20 | 451 |
| 2025/11/21 | 444 |
| 2025/11/22 | 435 |
| 2025/11/23 | 424 |
| 2025/11/24 | 442 |
| 2025/11/25 | 448 |
| 2025/11/26 | 429 |
| 2025/11/27 | 436 |
| 2025/11/28 | 440 |
| 2025/11/29 | 439 |
| 2025/11/30 | 442 |
Copyright © Adthena. All rights reserved.
November began with 450 advertisers, peaking at 465 on the 3rd. A decline followed, reaching 424 on the 23rd. The month concluded with a slight recovery to 442 advertisers.
Here we’re looking at the Top 10 biggest industry movers by market share gains and losses for the last 30 days.
Copyright © Adthena. All rights reserved.
Kisqali.com saw the largest decline in click share at -1.85%, while mayoclinic.org experienced the highest increase at 0.85%.
Take a look at the Top 10 competitors in the industry by Share of Impressions over the last month.
| Date | mayoclinic.org | thermofisher.com | letschatcart.com | kisqali.com | themmrf.org | breyanzi.com | imbcr.org | lilly.com | leukemiarf.org | her2know.com |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025/11/01 | 3.83% | 0.06% | 2.47% | 2.98% | 2.19% | 4.22% | 3.7% | 5.53% | 3.07% | 2.44% |
| 2025/11/02 | 3.66% | 0.04% | 4.69% | 1.87% | 1.34% | 5.73% | 6.5% | 3.56% | 2.11% | 1.59% |
| 2025/11/03 | 2.99% | 0.07% | 1.41% | 3.22% | 2.56% | 3.71% | 2.1% | 5.91% | 1.49% | 1.89% |
| 2025/11/04 | 3.72% | 0.14% | 2.48% | 2.09% | 3.42% | 5.44% | 1.14% | 5.04% | 1.9% | 1.68% |
| 2025/11/05 | 4.08% | 0.34% | 4.6% | 1.86% | 7.06% | 4.54% | 5.28% | 3.5% | 2.01% | 2.54% |
| 2025/11/06 | 4.97% | 6.43% | 0.26% | 3.53% | 1.72% | 3.42% | 3.8% | 4.01% | 2.16% | 2.26% |
| 2025/11/07 | 4.54% | 3.34% | 2.82% | 2.63% | 5.7% | 3.03% | 7.44% | 3.9% | 1.81% | 2.2% |
| 2025/11/08 | 3.45% | 3.07% | 3.36% | 3.51% | 2.43% | 4.02% | 1.66% | 4.15% | 1.17% | 2.11% |
| 2025/11/09 | 3.2% | 2.33% | 0.38% | 2.91% | 7.32% | 2.63% | 7.89% | 4.19% | 3.4% | 1.58% |
| 2025/11/10 | 7.57% | 5.49% | 2.62% | 2.28% | 6.23% | 3.86% | 1.34% | 3.31% | 1.47% | 2.01% |
| 2025/11/11 | 4% | 6.07% | 2.48% | 3.38% | 7.48% | 4.77% | 1.18% | 3.79% | 0.15% | 2.52% |
| 2025/11/12 | 4.86% | 2.55% | 5.62% | 2.5% | 4% | 3.46% | 3.17% | 4.4% | 1.81% | 2.04% |
| 2025/11/13 | 4.52% | 4.5% | 4.78% | 2.49% | 3.87% | 3.32% | 1.14% | 3.73% | 0.52% | 1.84% |
| 2025/11/14 | 2.02% | 2.33% | 4.79% | 3.17% | 3.07% | 3.75% | 4.67% | 3.41% | 0.89% | 1.67% |
| 2025/11/15 | 4.64% | 2.78% | 2.56% | 3.39% | 4.9% | 4.6% | 1.47% | 4.45% | 1.79% | 2.82% |
| 2025/11/16 | 4.08% | 0.06% | 2.94% | 1.97% | 9.43% | 4.08% | 4.35% | 3.01% | 1.55% | 1.56% |
| 2025/11/17 | 1.23% | 6.86% | 3.31% | 2.49% | 6.45% | 3.47% | 1.84% | 2.37% | 1.29% | 1.97% |
| 2025/11/18 | 6.17% | 3.15% | 2.6% | 1.59% | 4.92% | 4.47% | 0.53% | 3.64% | 1.54% | 2.91% |
| 2025/11/19 | 3.89% | 1.01% | 3.89% | 0.36% | 3.09% | 4.35% | 0.27% | 4.22% | 1.38% | 2.85% |
| 2025/11/20 | 4.27% | 0.63% | 1.78% | 0.27% | 3.85% | 4.26% | 2.25% | 3.82% | 1.63% | 2.21% |
| 2025/11/21 | 4.03% | 4.24% | 0.41% | 0.21% | 6.93% | 4.23% | 2.49% | 3.56% | 2.13% | 2.14% |
| 2025/11/22 | 3.09% | 1.71% | 5.91% | 0.24% | 1.74% | 4.55% | 4.4% | 3.26% | 1.66% | 2.72% |
| 2025/11/23 | 2.77% | 1.98% | 5.58% | 0.16% | 2.06% | 3.11% | 0.86% | 2.67% | 0.46% | 3.33% |
| 2025/11/24 | 3.74% | 4.14% | 4.95% | 0.68% | 5.61% | 3.99% | 1.69% | 2.32% | 1.12% | 1.61% |
| 2025/11/25 | 3.88% | 8.64% | 0.37% | 2.33% | 4.8% | 4.58% | 1.49% | 2.85% | 1.48% | 1.11% |
| 2025/11/26 | 5.42% | 2.56% | 4.94% | 3.27% | 4.41% | 4.44% | 1.63% | 3.35% | 1.15% | 0.9% |
| 2025/11/27 | 4.93% | 3.34% | 1.82% | 2.58% | 8.45% | 3.97% | 2.56% | 2.54% | 2.51% | 1.69% |
| 2025/11/28 | 6.43% | 1.45% | 5.99% | 2.66% | 6.91% | 4.09% | 1.33% | 2.27% | 2.4% | 0.96% |
| 2025/11/29 | 9.27% | 1.49% | 0.83% | 3.31% | 4.36% | 4.49% | 1.46% | 3.06% | 2.7% | 1.37% |
| 2025/11/30 | 5.15% | 4.54% | 4.21% | 3.14% | 3.08% | 2.72% | 2.52% | 2.49% | 1.78% | 0.71% |
Copyright © Adthena. All rights reserved.
In November 2025, mayoclinic.org saw a significant rise in PPC impressions, peaking at 9.27% on the 29th. Thermofisher.com had a notable spike on the 25th with 8.64%. The month concluded with mayoclinic.org leading the impressions.
Ever wondered how your rivals’ ads are doing? Here we can see the top-performing ads in the industry over the last month.
Thanks to IMBCR research, Dr. Berenson's patients have the world's longest survival rate.
CAR T-Cell Therapy Helps Your Immune System Fight Against Certain Relapsed Blood Cancers. View Resources to Learn if CAR T-Cell Therapy May be Right for You.
Learn how ongoing research on novel binding domains can impact the future of BCMA Therapy.
Learn about Acute Myeloid Leukemia (AML) in children, including symptoms, treatments, and research advancements improving survival rates
Multiple myeloma is the second most common blood cancer in the United States. Learn more.
Copyright © Adthena. All rights reserved.
In the competitive landscape of Google PPC, five top-performing ads reveal a tapestry of themes and messaging. IMBCR.org highlights groundbreaking research with Dr. Berenson’s patients achieving the longest survival rates. Letschatcart.com educates on CAR T-Cell Therapy, empowering patients with resources. Mmissionpossible.com delves into BCMA Therapy’s future, while Stbaldricks.org focuses on improving survival rates in pediatric AML. Thermofisher.com emphasizes the prevalence of multiple myeloma, offering educational insights. Each ad uniquely positions itself, weaving a narrative of hope, innovation, and education in oncology.
Imagine being able to instantly see your competitors Market Share, Share of Spend and their top performing ad copy so you can effectively benchmark your own performance.
Adthena’s PPC Market Share reports provide an instant view of performance insights across hundreds of sub-industries – so you can do just that.
How to use the US Pharma & Biotech Oncology November 2025 Report
Think of these reports as a cheat sheet for your industry’s search landscape. Check out this short article for a breakdown of each report and how they can benefit your strategy.
Data within the US Pharma & Biotech Oncology November 2025 Report is aggregated every month, highlighting the most significant changes from the previous period.
We use observed data from Google’s search results pages. With 20 million Google SERPs indexed per day. Adthena forms a global index of publicly available searches on Google.
On top of observed data, our data science models and patented technology expand on the insights through estimated metrics like market share, share of spend, and more.
We have 12 years of historical data across industries and our custom-built AI models learn from continuously updated data every day.
The US Pharma & Biotech Oncology November 2025 Report is powered by Adthena’s Whole Market View, which is the patented technology that drives value for our 300 enterprise customers.
Our unique approach to search intelligence ingests Google’s Keyword Planner into its learning models, providing a more accurate and up-to-date view of keyword data compared to traditional panel data methods.
With daily data collection and updates, Adthena offers a closer-to-real-time view of the Google Ads auction, enabling timely insights and adjustments.
Adthena focuses specifically on Google Ads, providing a deep dive into the channel and offering detailed insights into its workings. By processing 10 TB of new data daily and employing AI and machine learning models to analyze millions of Google Ads searches per second, Adthena provides a comprehensive and in-depth view of the competitive landscape.
Learn more about our data accuracy
Yes. The US Pharma & Biotech Oncology November 2025 Report aggregates data from across both device types and Google Shopping.
The US Pharma & Biotech Oncology November 2025 Report is for enterprise brands and agencies who want quick and high-level, historical benchmarks that are easily digestible and reveal insights, trends and market winners relevant to their own industry.
Our search consultants can introduce you to data that is specific to your organization, based on the size of the relevant search term and competitor universe, and the geographies that need monitoring.
Complete the form below to get started.
Ask Arlo leverages real-time GenAI to answer customers’ questions about their own search data and receive instant, tailored responses and reports directly within the Adthena platform.
With millions of Google SERPs indexed every day, Arlo never misses a trick and makes sure you’re always up to date.
The data on this page is just a sample of the billions of data points we hold at Adthena. The insights generated by Ask Arlo, leverage real-time GenAI to answer questions about your search data.
Our search consultants can introduce you to Whole Market View data that is specific to your organization, based on the size of the relevant search term and competitor universe, and the locations that you need monitoring.